#None #Rejuran #PharmaResearch #VIVACY

PharmaResearch Completes REJURAN Presentation Tour in Western Europe

PharmaResearch Co. Ltd, a South Korean company specializing in regenerative medicine, has wrapped up its presentation tour for REJURAN, a skin-stimulating product based on PDRN, across five markets in Western Europe. This tour was a strategic step to broaden the brand’s footprint in this region.

In anticipation of expanding REJURAN's market presence, the tour served as a vital platform for unveiling PharmaResearch’s DNA optimization technology (DOT™) to healthcare professionals. According to the company, the events led to a robust interest in REJURAN, with attendees actively engaging and raising numerous inquiries regarding the product's features and practical applications.

The series of presentations kicked off with a symposium in the Benelux region on April 22 and 23, followed by events in the UK on April 28 and Switzerland on April 30. The Benelux symposium, strategically located near the Belgian and Dutch border, drew healthcare professionals from both nations, while the UK event attracted a diverse group of health experts and industry stakeholders.

International experts from PharmaResearch led the symposium sessions, sharing clinical results, treatment protocols, and real-world application examples. The discussions addressed the full spectrum of REJURAN, including expanded use products for the face, REJURAN I targeted for delicate areas like under the eyes, and REJURAN S which focuses on wrinkles and scars.

The presentation tour was not only pivotal for immediate engagement but also aimed at enhancing REJURAN's growth across Europe. Following its first European market launch in January, PharmaResearch has been actively developing its local distribution network. Positive reactions have led to the expansion of product offerings and the enhancement of clinical training programs in the region.

Building on the momentum from this initial tour across five Western European markets, PharmaResearch plans to continue engagements in Italy in May, Poland in June, and France in September. The company is also looking to establish a presence in Germany and further European markets throughout the second half of the year, solidifying REJURAN's regional footprint.

Vera Tual, the Client Manager at VIVACY, PharmaResearch's European partner, noted, “Although REJURAN is still in early stages in Europe, the enthusiasm among healthcare professionals has been palpable throughout the presentation tour. The depth of inquiries regarding the product's features and practical applications underscores REJURAN’s established reputation in Asia, which is successfully creating a buzz in Europe. This response signals that REJURAN is quickly gaining recognition among European healthcare practitioners as a new benchmark product for their aesthetic practices.”

Tual also expressed the importance of REJURAN in expanding VIVACY's aesthetic product portfolio, providing an excellent opportunity to connect with a wider network of healthcare professionals across Europe. She confirmed the commitment to closely collaborate with PharmaResearch for a successful brand rollout in various markets.

A PharmaResearch representative commented on the growing interest in PDRN-based injectables within Europe, noting that while the market is still emerging, this is the ideal moment to introduce REJURAN as a trusted skin booster, supported by their DOT™ technology and clinical expertise.

The representative continued, “REJURAN is gaining traction in Europe more rapidly than we anticipated. This indicates the pre-existing global presence of REJURAN in other markets, the strength of our DOT™ technology, and the relevance of our product range for healthcare professionals. Given the early responses, we have revised our internal goals upwards and will continue to expand distribution and educational programs in Europe.”

About PharmaResearch

PharmaResearch is a pioneering biopharmaceutical company dedicated to improving quality of life through regenerative medicine. Its diverse portfolio includes pharmaceuticals, medical devices, cosmetics, and health supplements utilizing DOT™ PDRN and DOT™ PN core ingredients, protected by multiple patents. PharmaResearch is headquartered in Gangneung-si, Gangwon-do, South Korea, with a US subsidiary in Costa Mesa, California.

For more information, visit PharmaResearch.

About VIVACY Laboratories

Laboratoires VIVACY is a French manufacturer of high-end hyaluronic acid medical devices, founded in 2007 and based in Paris. Renowned for its proprietary IPN-Like technology, VIVACY is particularly recognized for its STYLAGE® and DESIRIAL® dermal filler products—the first injectable solution globally for functional and aesthetic gynecology. VIVACY has recently entered into strategic partnerships with Burgeon Biotechnology for the NOVUMA® CaHA biostimulator and with PharmaResearch for the exclusive European distribution of the REJURAN® PN skin booster. With products manufactured at their state-of-the-art facility in Archamps Technopole, France, VIVACY is present in over 85 countries.

For additional details, check VIVACY.